A phase 1, open label study of pharmacokinetic drug interaction between armodafinil and risperidone in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 23 Sep 2015
At a glance
- Drugs Armodafinil (Primary) ; Risperidone (Primary)
- Indications Hypersomnia
- Focus Pharmacokinetics
- Sponsors Teva Branded Pharmaceutical Products R&D
- 23 Sep 2015 New trial record
- 19 Sep 2015 Results published in the Clinical Drug Investigation.